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Pulse pressure (PP) is the arithmetic diﬀerence between
systolic blood pressure (SBP) and diastolic blood
pressure (DBP), commonly measured as brachial cuﬀ
pressures. There is a progressive increase in blood pres-
sure (BP) with ageing in industrialized societies, begin-
ning in childhood and continuing into adulthood. This
trend is associated with a greater increase in SBP than
diastolic DBP during the middle adult years. Whereas
SBP continues to rise until the eighth or ninth decade,
DBP tends to remain constant or decline after the
ﬁfth or sixth decade; as a consequence, PP increases
progressively with age and the rate of rise accelerates
after age 50 years. There also is a sex diﬀerence in BP
trends; women’s BP starts lower than men’s, catches
up by the sixth decade and frequently becomes
slightly higher thereafter.1,2 These natural trends are
increasingly modiﬁed by contemporary treatment of
hypertension.
The prognostic importance of PP has been widely
described in various patient populations, starting with
the seminal Framingham cohort.3 Elevated DBP has
long been associated with increased cardiovascular
risk (CVR), albeit in younger populations.4 SBP is dir-
ectly and linearly related to CVR over a wide range of
ages. With advancing age, there is a decline in DBP and
in the role of DBP in predicting coronary heart disease
risk. DBP becomes inversely related to CVR, especially
in multivariate models including SBP.3 With increasing
age, there is a gradual shift from DBP to SBP and then
to PP as predictors of CVR. In patients <50 years of
age DBP is the strongest predictor. Age 50 to 59 years is
a transition period when all three BP indices are com-
parable predictors, and from 60 years of age on, DBP is
negatively related to CVR so that PP becomes superior
to SBP as a risk predictor.5 These Framingham data
were largely conﬁrmed in the huge Multiple Risk
Factor Intervention Trial (MRFIT) database.6 In men
screened for MRFIT (age 35–57), PP was not as strong
a predictor of cardiovascular mortality as SBP and
DBP. In contrast to DBP, which displays a quadratic
relation with cardiovascular risk, both mean BP and PP
have a linear, independent relation with risk.7 The best
predictor function among the possible linear combin-
ations of SBP and DBP is similar to that of PP, sug-
gesting that their association is real and not merely a
statistical artefact caused by the correlation between
SBP and PP.8 PP therefore combines prognostic infor-
mation related to increased SBP and decreased DBP.
What is the underlying mechanism of increased BP
components? Haemodynamics tell us that an increase in
SBP with ﬁxed PP occurs when there are parallel
increases in SBP and DBP; this is a consequence of a
rise in mean arterial pressure and peripheral vascular
resistance. This typically occurs in younger hyperten-
sives. An increase in SBP together with an increase in
PP occurs as a consequence of a rise in large artery
stiﬀness. DBP may slightly increase, remain unchanged
or even decrease.9 This typically occurs in aged hyper-
tensives. Increased SBP and PP may also reﬂect
increased stroke volume. This sometimes happens in
young hypertensives.
Physiologically, PP is determined by arterial stiﬀ-
ness, ventricular ejection, and by wave reﬂections.8
. Arterial stiﬀness. During systole, the aortic wall
expands, limiting the rise in SBP. In diastole, the
aorta contracts, due to elastic recoil. This contrib-
utes to elevating DBP and perfusion pressure. The
pulsatile ﬂow therefore is transformed in a more con-
tinuous perfusion ﬂow.9 With age and hypertension,
these reciprocal properties are progressively lost.
A stiﬀer aortic wall and loss of elasticity contribute
to increased PP and to increased pulsatility at the
target organs.
. Ventricular ejection. It was long believed that ven-
tricular ejection would not aﬀect age-related changes
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in PP. However, with age and hypertension, systolic
ventricular elastance increases in order to match the
increased arterial elastance, accordingly reduced
arterial compliance, thereby preserving ventricular-
arterial coupling, stroke volume and ejection frac-
tion.10 In the Framingham oﬀspring cohort, an
age-related increase in aortic stiﬀness, as opposed
to peripheral arterial stiﬀness, was associated with
increasing forward wave amplitude and PP. This
phenomenon may facilitate forward transmission
of potentially deleterious pressure pulsations into
the periphery, thereby providing a pathophysio-
logical link between PP and target organ damage.11
. Wave reﬂection. In young and healthy subjects,
the forward travelling pressure wave is reﬂected at
the sites of impedance mismatch and returns to the
heart, contributing to diastolic perfusion pressure.
With progressing aortic stiﬀening, the forward
wave travels faster and returns earlier to the heart,
boosting late-systolic pressure.12 These reﬂected
waves are stronger, due to the impact of stronger
forward wave on backward wave pressures.
Backward waves contribute to age-related increases
in aortic PP across the adult lifespan.13 The bulk of
wave reﬂections arise at the lower body, travel back
to the heart and penetrate the carotid artery as a
forward wave, which increases pulsatile pressure
and ﬂow in the coronary and cerebrovascular
bed.14 The magnitude of wave reﬂection appears to
be independently associated with diastolic dysfunc-
tion, left ventricular hypertrophy and CVR (sum-
marized in Nagueh et al.15). The prognostic value
of wave reﬂection for incident heart failure is inde-
pendent of, and as potent as, SBP and DBP.16
A paper in this issue of the EJPC17 analysed the
prognostic value of high PP (HPP; PP 60mmHg) in
The Campania Salute Registry, a big cohort of treated
hypertensive patients. A total of 7336 patients were
included, with a mean age of 53.6 years. In this
cohort 32% of the patients presented with HPP.
Patients with HPP were older, were more likely to be
women, had much higher BP at the start of the study
(160/89mmHg versus 135/89), more diabetes, lower
glomerular ﬁltration rate (eGFR), and were treated
with more anti-hypertensive drugs. Patients with HPP
had slightly greater left ventricle (LV) chamber dimen-
sion and stroke index, greater LV mass and relative
wall thickness, and more prevalent carotid plaques.
Major adverse cardiovascular end-points (MACE) at
their ﬁrst presentation were deﬁned as fatal or non-
fatal myocardial infarction or stroke, and sudden
death. In the ﬁnal Cox regression model, the condition
of high PP was adjusted for age and sex, presence of
diabetes, left ventricular hypertrophy, carotid plaque,
classes of antihypertensive medications and mean arter-
ial pressure. HPP patients had 57% increased hazard of
MACE, compared with normal pulse pressure (NPP).
A similar model was run changing PP with its two com-
ponents, SBP and DBP. In this model, both SBP and
DBP were independent predictors of cardiovascular
events, but in opposite directions. As could have
expected, SBP exhibited a direct relation with probabil-
ity of events, whereas the relation of DBP was negative.
It may appear as a semantic discussion, but it is not
obvious to adjust one of the most readily available clin-
ical parameters, for laboratory or imaging parameters.
In the present study, these adjustments were done in
order to show that PP is related to CVR, even inde-
pendently of well-known structural markers of target
organ damage. It is, however, unexpected that the
authors did not adjust for eGFR. This inclusion
could have weakened the association between PP and
MACE.18
The study provides conﬁrmatory evidence that PP is
a superior predictor of CVR to SBP, DBP or mean BP.
Some aspects are of particular interest. The ﬁrst is the
mean age of the population (54 years). At this age PP is
not yet a strong prognosticator in the Framingham or
MRFIT population.5,6 Albeit that in the MRFIT trial,
men 45–57 years old, with higher SBP and lower DBP
(discordant elevation) yielded a greater risk of cardio-
vascular mortality. It is obvious that the patients with
HPP of the present investigation represent a high-risk
population. It is of further interest to observe the huge
diﬀerence in BP values between HPP and NPP patients
at the start of the study. The authors redid their ana-
lysis using BP values during follow-up and kept the
prognostic signiﬁcance. The authors report an average
BP on follow up of <140/90mmHg, while initial aver-
age was 143/89mmHg. It remains uncertain how well
BP was controlled in this survey. An interesting add-
itional analysis was performed on patients with ade-
quately controlled BP during follow-up. In the
corresponding adjusted Cox regression, PP came out
as not signiﬁcant. Uncontrolled SBP therefore appears
to be a confounder of the present ﬁndings.
Increased pulse pressure reﬂects aortic stiﬀening,
increased wave strength (forward and backward), pre-
mature reﬂection and increased peripheral pulsatility of
ﬂow. These alterations aﬀect target organ damage and
independently predict cardiovascular complications.
The implications of the study under scrutiny and the
preceding studies on the prognostic value of PP may be
easily derived. Any combination of two of the three BP
measures provides more information about CVR than
a single measure. Since pulse pressure is simply the dif-
ference between SBP and DBP, given predictive infor-
mation from SBP and DBP considered together, PP
cannot add further information.6 It, however, is a
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powerful predictor of CVR, especially in an older popu-
lation. In order to use the prognostic information of BP
measurements you should select two BP components,
either SBP and DBP or PP with DBP or mean BP. The
choice may depend on the population characteristics
under scrutiny.
It ﬁnally has to be noted that the present investiga-
tion showed that PP remained a signiﬁcant predictor in
a multivariate analysis. It, however, did not show that
adding PP to a panel would signiﬁcantly improve CVR
prediction (receiving operating characteristic and net
reclassiﬁcation index). For any ‘newcomer’ measure-
ment, closely related to an already settled one, the like-
lihood of improving prediction of the person-speciﬁc
absolute cardiovascular risk in a clinically relevant
way is low.19,20 It remains to be investigated whether
substituting SBP by PP and adding it to DBP or mean
BP enhances CVR prediction.
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